| Prev Close | 138.05 |
| Day Low/High | 136.40 / 140.17 |
| 52 Wk Low/High | 86.88 / 154.24 |
Jazz Pharmaceuticals Plc (JAZZ)
139.58
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 55.46B |
| Market Cap | 7.66B |
| P/E Ratio | 59.76 |
| Div & Yield | N.A. (N.A) |
Latest News
Bearish Bets: 2 Stocks You Really Should Consider Shorting This Week
These names are showing both technical and quantitative deterioration.
Bullish Looking Jazz Pharmaceutical Gets a Boost From a Quant Buy Recommendation
Let's review the charts and indicators of this Dublin-based biopharmaceutical.
Jazz (Pharmaceuticals) Has Pizzazz With Quant Upgrade and Bullish Charts
Two reasons to buy a stock are better than one. Right?
2 Stocks You Really Should Consider Shorting This Week
These 'Bearish Bets' are showing both technical and quantitative deterioration.
New Year's Investing Resolutions
The market's day-to-day extreme volatility tested even the most seasoned investors. Adhering to portfolio principles can help.
Trader's Daily Notebook: For a Decline, It Sure Was Smooth
But we could see more volatility in the market.
Biotech M&A Waking Up After Long Nap
The uptick in the small- and mid-cap space bodes well for future capital appreciation.
Mylan Deal the Rx for Drug Stocks
Even the second-tier biotechs are taking off.
Nasdaq 5000 Is Meaningless
Stay focused on price and remember that the market's riding a trend.
A Bit Late to Two Parties
But not too late to stop chasing entries.
Fitz Bits: GoPro Is Killing the Bears
I think it's going to hit $100 in the next few months.
The Trader Daily
The iShares Transportation Average (IYT) is one to watch.
The Trader Daily
Don't batten down the hatches yet.
Get Used to the New Market Reality
Algos think faster and react faster than humans can.
Wait for Your Cue in Jazz Pharma
The technicals look good, but don't dive in just yet.
This Froth Has to Be Reined In
The public market is currently divorced from the dazzling IPOs -- and that's always a bad sign.
A Trio of Breakouts
Jazz Pharma, Qihoo and Rite-Aid are all on fire today.
Biotech Remains on Fast Track
Even after a run, some stocks still offer growth.
Going Solar
The group's been leading and it should continue to perform in 2014.
The Action Is High
But trust in this market is low.
Music to My Ears
Here's why I like a lower opening.
